HOME

ABOUT US

Actinogen Medical is focused on the treatment of Alzheimer’s Disease and mild cognitive impairment, a transitional stage of cognitive impairment between normal aging and the more serious conditions of Alzheimer’s and dementia.

It is developing a novel drug to treat the condition and other age-related neurodegenerative diseases.

SHARE PRICE INFORMATION

Data provided by asx.com.au. Prices are delayed by at least 20 minutes.

Code: ...

Share Price: ...

Last Updated: ... ...

HOW XANAMEM WORKS

ASX ANNOUNCEMENTS

SUBSCRIBE TO OUR NEWSLETTER

You can subscribe to receive all company announcements through our Email Alerts service. Please provide your details below to subscribe to our distribution list.
Name
Email *